Literature DB >> 23142613

Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 8. High affinity ligands for opioid receptors in the picomolar Ki range: oxygenated N-(2-[1,1'-biphenyl]-4-ylethyl) analogues of 8-CAC.

Mark P Wentland1, Sunjin Jo, Joseph M Gargano, Melissa A VanAlstine, Dana J Cohen, Jean M Bidlack.   

Abstract

N-[2-(4'-methoxy[1,1'-biphenyl]-4-yl)ethyl]-8-CAC (1) is a high affinity (K(i)=0.084 nM) ligand for the μ opioid receptor and served as the lead compound for this study. Analogues of 1 were made in hopes of identifying an SAR within a series of oxygenated (distal) phenyl derivatives. A number of new analogues were made having single-digit pM affinity for the μ receptor. The most potent was the 3',4'-methylenedioxy analogue 18 (K(i)=1.6 pM).
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23142613      PMCID: PMC3508289          DOI: 10.1016/j.bmcl.2012.10.081

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

1.  Design and synthesis of novel dimeric morphinan ligands for kappa and micro opioid receptors.

Authors:  John L Neumeyer; Ao Zhang; Wennan Xiong; Xiao-Hui Gu; James E Hilbert; Brian I Knapp; S Stevens Negus; Nancy K Mello; Jean M Bidlack
Journal:  J Med Chem       Date:  2003-11-20       Impact factor: 7.446

2.  Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 4. Opioid receptor binding properties of 8-[N-(4'-phenyl)-phenethyl)carboxamido] analogues of cyclazocine and ethylketocycalzocine.

Authors:  Mark P Wentland; Melissa VanAlstine; Robert Kucejko; Rongliang Lou; Dana J Cohen; Amy L Parkhill; Jean M Bidlack
Journal:  J Med Chem       Date:  2006-09-07       Impact factor: 7.446

Review 3.  Cyclazocine revisited.

Authors:  S Archer; S D Glick; J M Bidlack
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

4.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

5.  8-Carboxamidocyclazocine analogues: redefining the structure-activity relationships of 2,6-methano-3-benzazocines.

Authors:  M P Wentland; R Lou; Y Ye; D J Cohen; G P Richardson; J M Bidlack
Journal:  Bioorg Med Chem Lett       Date:  2001-03-12       Impact factor: 2.823

6.  Effects of the mixed-action kappa/mu opioid agonist 8-carboxamidocyclazocine on cocaine- and food-maintained responding in rhesus monkeys.

Authors:  Glenn W Stevenson; Mark P Wentland; Jean M Bidlack; Nancy K Mello; S Stevens Negus
Journal:  Eur J Pharmacol       Date:  2004-12-15       Impact factor: 4.432

7.  Syntheses and opioid receptor binding affinities of 8-amino-2,6-methano-3-benzazocines.

Authors:  Mark P Wentland; Yingchun Ye; Christopher L Cioffi; Rongliang Lou; Qun Zhou; Guoyou Xu; Wenhu Duan; Christoph M Dehnhardt; Xufeng Sun; Dana J Cohen; Jean M Bidlack
Journal:  J Med Chem       Date:  2003-02-27       Impact factor: 7.446

8.  Cyclazocine: comparison to hydromorphone and interaction with cocaine.

Authors:  K L Preston; A Umbricht; J R Schroeder; M E Abreu; D H Epstein; W B Pickworth
Journal:  Behav Pharmacol       Date:  2004-03       Impact factor: 2.293

9.  Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 5. Opioid receptor binding properties of N-((4'-phenyl)-phenethyl) analogues of 8-CAC.

Authors:  Melissa A VanAlstine; Mark P Wentland; Dana J Cohen; Jean M Bidlack
Journal:  Bioorg Med Chem Lett       Date:  2007-09-29       Impact factor: 2.823

10.  8-Carboxamidocyclazocine: a long-acting, novel benzomorphan.

Authors:  Jean M Bidlack; Dana J Cohen; Jay P McLaughlin; Rongliang Lou; Yingchun Ye; Mark P Wentland
Journal:  J Pharmacol Exp Ther       Date:  2002-07       Impact factor: 4.030

  10 in total
  2 in total

1.  Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 9: Synthesis, characterization and molecular modeling of pyridinyl isosteres of N-BPE-8-CAC (1), a high affinity ligand for opioid receptors.

Authors:  Melissa A VanAlstine; Mark P Wentland; Juan Alvarez; Qing Cao; Dana J Cohen; Brian I Knapp; Jean M Bidlack
Journal:  Bioorg Med Chem Lett       Date:  2013-02-08       Impact factor: 2.823

2.  Toward a Universal μ-Agonist Template for Template-Based Alignment Modeling of Opioid Ligands.

Authors:  Zhijun Wu; Victor J Hruby
Journal:  ACS Omega       Date:  2019-10-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.